| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8783745 | Reproductive BioMedicine Online | 2018 | 6 Pages |
Abstract
This study shows that patients treated with FSS for FIGO stage I EOC do not have an impaired survival compared with patients treated with RS. Nevertheless, the conclusion must be interpreted with caution due to the limited number of patients and the retrospective nature of the study. Larger studies are needed before conclusions can be drawn.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Nora Elisabeth Hedbäck, Mona Aarenstrup Karlsen, Claus Kim Høgdall, Mikkel Rosendahl,